The U.S. Food and Drug Administration today made public filing checklists used internally by Center for Drug Evaluation and Research (CDER) staff to determine if a submitted application is complete and reviewable.
Similar Posts
AlzClipp / UniUni – 711274 – 07/29/2025
Unapproved New Drugs/MisbrandedPurushothaman Damodara Kumaran, M.D. – 721325 – 12/22/2025
In Vivo Bioavailability-Bioequivalence Studies – ClinicalNatural Disaster Preparedness and Response | Drugs
Stay informed on FDA’s guidance for drugs used in natural disaster preparedness and response. Learn about emergency drug supplies, FDA-approved treatments, and safety measures for public health during disasters like hurricanes, floods, and more.Early Alert: Trividia Health Issues Correction for TRUE METRIX Blood Glucose Monitoring Systems
Trividia recommends that device users who receive an E-5 error code and are experiencing symptoms of high glucose should seek medical care immediatelyBroselow Pediatric Emergency Rainbow Tape Recall: AirLife Removes Certain Broselow Pediatric Emergency Rainbow Tapes due to Misprinted Information
Certain Broselow Pediatric Emergency Rainbow Tapes were manufactured with incorrect information on the tape.VITAFER-L Gold 20ml may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on various websites, including www.amazon.com.